BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30272821)

  • 1. Mutant p53
    Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
    J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells.
    Hernández-Reséndiz I; Román-Rosales A; García-Villa E; López-Macay A; Pineda E; Saavedra E; Gallardo-Pérez JC; Alvarez-Ríos E; Gariglio P; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2015 Dec; 1853(12):3266-78. PubMed ID: 26434996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.
    Rodríguez-Enríquez S; Carreño-Fuentes L; Gallardo-Pérez JC; Saavedra E; Quezada H; Vega A; Marín-Hernández A; Olín-Sandoval V; Torres-Márquez ME; Moreno-Sánchez R
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1744-51. PubMed ID: 20654728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?
    Cheng Y; Chen G; Hong L; Zhou L; Hu M; Li B; Huang J; Xia L; Li C
    Ann Diagn Pathol; 2013 Jun; 17(3):305-11. PubMed ID: 23375385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
    Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
    Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
    Fu Z; Chen D; Cheng H; Wang F
    Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
    Bai H; Ge S; Lu J; Qian G; Xu R
    J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.
    Rohwer N; Dame C; Haugstetter A; Wiedenmann B; Detjen K; Schmitt CA; Cramer T
    PLoS One; 2010 Aug; 5(8):e12038. PubMed ID: 20706634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells.
    Plecitá-Hlavatá L; Ježek J; Ježek P
    J Bioenerg Biomembr; 2015 Dec; 47(6):467-76. PubMed ID: 26449597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level.
    Hubert A; Paris S; Piret JP; Ninane N; Raes M; Michiels C
    J Cell Sci; 2006 Aug; 119(Pt 16):3351-62. PubMed ID: 16882692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of hypoxia-inducible factor 1alpha on the biological characteristics of the SiHa uterine cervix cancer cell line.
    Tang B; Qu Y; Zhao F; Mao M; Tang J; Li X; Ferriero D; Mu D
    Int J Gynecol Cancer; 2009 Jul; 19(5):898-904. PubMed ID: 19574782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
    Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
    Yu M; Pan Q; Li W; Du T; Huang F; Wu H; He Y; Wu X; Shi H
    Phytomedicine; 2023 Dec; 121():155045. PubMed ID: 37742526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.
    Remels AH; Gosker HR; Verhees KJ; Langen RC; Schols AM
    Endocrinology; 2015 May; 156(5):1770-81. PubMed ID: 25710281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.
    Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC
    Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia differentially regulates muscle oxidative fiber type and metabolism in a HIF-1α-dependent manner.
    Slot IG; Schols AM; Vosse BA; Kelders MC; Gosker HR
    Cell Signal; 2014 Sep; 26(9):1837-45. PubMed ID: 24794533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypoxia alters mitochondrial composition in human macrophages.
    Fuhrmann DC; Wittig I; Heide H; Dehne N; Brüne B
    Biochim Biophys Acta; 2013 Dec; 1834(12):2750-60. PubMed ID: 24140568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Lai JH; Jan HJ; Liu LW; Lee CC; Wang SG; Hueng DY; Cheng YY; Lee HM; Ma HI
    Neuro Oncol; 2013 Oct; 15(10):1330-41. PubMed ID: 23911596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.